JNGLX
Price
$65.47
Change
+$0.17 (+0.26%)
Updated
Aug 11 closing price
Net Assets
4.28B
LHCQX
Price
$18.13
Change
+$0.08 (+0.44%)
Updated
Aug 11 closing price
Net Assets
7.28M
Interact to see
Advertisement

JNGLX vs LHCQX

Header iconJNGLX vs LHCQX Comparison
Open Charts JNGLX vs LHCQXBanner chart's image
Janus Henderson Global Life Sciences D
Price$65.47
Change+$0.17 (+0.26%)
VolumeN/A
Net Assets4.28B
Lord Abbett Health Care R3
Price$18.13
Change+$0.08 (+0.44%)
VolumeN/A
Net Assets7.28M
JNGLX vs LHCQX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
JNGLX vs. LHCQX commentary
Aug 12, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JNGLX is a Buy and LHCQX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
JNGLX has more cash in the bank: 4.29B vs. LHCQX (7.28M). LHCQX (0.36) and JNGLX (0.36) have matching dividends . JNGLX was incepted earlier than LHCQX: JNGLX (27 years) vs LHCQX (6 years). LHCQX (3.59) is less costly to investors than JNGLX (0.80). LHCQX is a more actively managed with annual turnover of: 88.00 vs. JNGLX (35.00). LHCQX has a lower initial minimum investment than JNGLX: LHCQX (0) vs JNGLX (2500). LHCQX annual gain was more profitable for investors over the last year : -6.71 vs. JNGLX (-16.15). JNGLX return over 5 years is better than : 0.13 vs. LHCQX (-1.26).
JNGLXLHCQXJNGLX / LHCQX
Total Expense Ratio0.801.2863%
Annual Report Gross Expense Ratio0.803.5922%
Fund Existence27 years6 years-
Gain YTD-3.565-4.39681%
Front LoadN/AN/A-
Min. Initial Investment25000-
Min. Initial Investment IRAN/AN/A-
Net Assets4.29B7.28M58,828%
Annual Yield % from dividends0.360.3699%
Returns for 1 year-16.15-6.71241%
Returns for 3 years1.471.8579%
Returns for 5 years0.13-1.26-10%
Returns for 10 years8.50N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SIFY8.650.45
+5.49%
Sify Technologies Ltd
ITRM0.720.01
+1.35%
Iterum Therapeutics plc
MRUS64.640.64
+1.00%
Merus NV
ALX215.88-2.41
-1.10%
Alexander's
ROP527.65-6.73
-1.26%
Roper Technologies